The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
| VISGX | |
| Total Expense Ratio | 0.19 |
| Annual Report Gross Expense Ratio | 0.19 |
| Fund Existence | 28 years |
| Gain YTD | 4.856 |
| Front Load | N/A |
| Min. Initial Investment | 3000 |
| Min. Initial Investment IRA | N/A |
| Net Assets | 39.7B |
| Annual Yield % from dividends | 0.43 |
| Returns for 1 year | -2.58 |
| Returns for 3 years | 39.44 |
| Returns for 5 years | 20.05 |
| Returns for 10 years | 135.75 |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TMED | 30.49 | 0.56 | +1.86% |
| T. Rowe Price Health Care ETF | |||
| IBB | 172.33 | 2.62 | +1.54% |
| iShares Biotechnology ETF | |||
| AUGZ | 43.39 | 0.27 | +0.64% |
| TrueShares Structured Outcome August ETF | |||
| PHYL | 35.51 | 0.12 | +0.34% |
| PGIM Active High Yield Bond ETF | |||
| GGME | 59.67 | 0.09 | +0.14% |
| Invesco Next Gen Media and Gaming ETF | |||